Niche Expertise P23 Labs is a high-complexity molecular diagnostics laboratory focusing on infectious disease testing, including COVID-19, STI panels, and respiratory pathogens, presenting an opportunity to expand offerings to hospitals, clinics, and specialty labs seeking comprehensive molecular testing partnerships.

Geographic Footprint With locations in Savannah, GA; Hilton Head, SC; and Guaynabo, PR, there is potential to upsell regional lab services, integrated patient testing programs, and rapid turnaround collaborations for multi-site healthcare providers and telemedicine platforms.

FDA EUA Experience Having an FDA EUA for COVID-19 testing demonstrates regulatory credibility and fast-path capabilities that can be leveraged to pursue partnerships for at-home, point-of-care, or urgent epidemic response testing with healthcare systems and employers.

Strategic Partnerships Past collaboration with BioIQ to offer combined COVID-19/flu and respiratory panels indicates openness to co-developed products and white-label or turnkey testing solutions for employers, insurers, and public health programs.

Growth Signals Revenue range and investable scale combined with a seasoned team suggests capacity to scale services, pursue contract research (CRO) opportunities, and expand payer engagement for faster reimbursement and larger trial or reference testing engagements.